Provided by Tiger Fintech (Singapore) Pte. Ltd.

Glaukos

82.35
+1.712.12%
Pre-market: 82.560.2100+0.26%06:19 EDT
Volume:903.36K
Turnover:74.20M
Market Cap:4.72B
PE:-49.81
High:83.26
Open:81.03
Low:80.85
Close:80.64
52wk High:163.71
52wk Low:77.10
Shares:57.35M
Float Shares:55.40M
Volume Ratio:1.03
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6531
EPS(LYR):-2.7746
ROE:-12.98%
ROA:-6.34%
PB:6.17
PE(LYR):-29.68

Loading ...

Stifel sees opportunity in Glaukos selloff, adds to Select List

TIPRANKS
·
Yesterday

3 Stocks That Could Be Undervalued By As Much As 29.5%

Simply Wall St.
·
Yesterday

Glaukos Receives Buy Rating from Analyst Ryan Zimmerman Due to Strong Growth and Promising Product Potential

TIPRANKS
·
Sep 11

Glaukos Price Target Maintained With a $118.00/Share by BTIG

Dow Jones
·
Sep 10

Glaukos Corporation Unveils Visionary Strategies and Innovations in Latest Investor Presentation

Reuters
·
Aug 12

UBS Adjusts Price Target on Glaukos Corp to $134 From $125, Maintains Buy Rating

MT Newswires Live
·
Jul 31

Stock Track | Glaukos Shares Plummet 5% Pre-Market as Analysts Adjust Price Targets

Stock Track
·
Jul 31

U.S. RESEARCH ROUNDUP-Equinix, Fair Isaac, Meta

Reuters
·
Jul 31

Glaukos Corp : Truist Securities Cuts Target Price to $126 From $130

THOMSON REUTERS
·
Jul 31

Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Jul 31

Glaukos Q2 Adj. EPS $(0.24) Beats $(0.26) Estimate, Sales $124.12M Beat $115.51M Estimate

Benzinga
·
Jul 31

BRIEF-Glaukos Q2 Sales USD 124.1 Million Vs. IBES Estimate USD 115.5 Million

Reuters
·
Jul 31

BUZZ-Glaukos slips after Medicare proposes cuts to eye surgery reimbursements

Reuters
·
Jul 15

Press Release: Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30

Dow Jones
·
Jul 09

Glaukos Corporation Secures EU MDR Certification for iStent infinite® and Leading MIGS Therapies, Marking First Approvals Under New EU Regulatory Framework

Reuters
·
Jun 26

Glaukos Corporation Conducted Annual Stockholders Meeting

Reuters
·
Jun 04

Glaukos Is Maintained at Underweight by Morgan Stanley

Dow Jones
·
May 06

Glaukos Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
May 03

Stock Track | Glaukos Surges 5% as Q1 Earnings Beat Expectations, Revenue Jumps 25%

Stock Track
·
May 03

Glaukos Price Target Cut to $135.00/Share From $140.00 by Truist Securities

Dow Jones
·
May 01